Evidence map›Paper›PMID 36571374›Full record

ReviewMedical gas research

The overlooked benefits of hydrogen-producing bacteria.

Yusuke Ichikawa, Haru Yamamoto, Shin-Ichi Hirano, Bunpei Sato, Yoshiyasu Takefuji, Fumitake Satoh

Open access · hybridAbstract readReview
In one paragraph

Review in Medical gas research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. An ethically guided preclinical device for phenotyping HAnimal models and experimental medicine · 2024
    Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Gut microbes
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Yusuke IchikawaMiZ Company Limited, Kamakura, Kanagawa, Japan; MiZ Inc., Newark, CA, USA, Japan.
Haru YamamotoMiZ Inc., Newark; Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA.
Shin-Ichi HiranoMiZ Company Limited, Kamakura, Kanagawa, Japan.
Bunpei SatoMiZ Company Limited, Kamakura, Kanagawa, Japan; MiZ Inc., Newark, CA, USA, Japan.
Yoshiyasu TakefujiData Science, Musashino University; Keio University, Tokyo, Japan.
Fumitake SatohMiZ Company Limited, Kamakura, Kanagawa, Japan; MiZ Inc., Newark, CA, USA, Japan.
Musashino University · JPUniversity of California, Berkeley · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intestinal bacteria can be classified into "beneficial bacteria" and "harmful bacteria." However, it is difficult to explain the mechanisms that make "beneficial bacteria" truly beneficial to human health. This issue can be addressed by focusing on hydrogen-producing bacteria in the intestines. Although it is widely known that molecular hydrogen can react with hydroxyl radicals, generated in the mitochondria, to protect cells from oxidative stress, the beneficial effects of hydrogen are not fully pervasive because it is not generally thought to be metabolized in vivo. In recent years, it has become clear that there is a close relationship between the amount of hydrogen produced by intestinal bacteria and various diseases, and this report discusses this relationship.

Indexed as

HydrogenOxidative StressBacteriaHumansHydroxyl RadicalHydrogenHydroxyl RadicalBacteroidesFirmicuteshydrogenhydrogen-producing bacteriahydroxyl radicalsIgA antibodynaked mole-ratsoxidative stressreactive oxygen species

Identifiers

PMID36571374
PMCPMC9979208
OpenAlexW4285741580

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.